Submit Deal

CATALIO CAPITAL MANAGEMENT

HQ - New York

Summary

Catalio Capital Management is a multi-strategy investment firm that focuses on breakthrough biomedical technology and innovative healthcare companies worldwide.

Deals Overview

Total Deals26

Valued Deals25

Total Value£ 2.89 B

Avg. Deal Size£ 115 M

Market Context

Senior Management

Jacob Vogelstein
Co-founder and Managing Partner
Edward Mathias
Chairman
George Petrocheilos
Founding Partner

Sort

23 May 2019|United States|Biotechnology

Target: FREENOME

Bidder: T. ROWE PRICE GROUP INC

17 Service Providers

3 Target | 14 Bidder

30 Dealmakers

8 Target | 24 Bidder

£ 126 M

Value

23 Nov 2020|Germany|Biotechnology

Target: ATAI LIFE SCIENCES

Bidder: CATALIO CAPITAL MANAGEMENT

11 Service Providers

4 Target | 7 Bidder

22 Dealmakers

13 Target | 9 Bidder

£ 93 M

Value

26 Feb 2015|United States|Medical Equipment

Target: FRACTYL LABORATORIES INC

Bidder: TAIWANIA CAPITAL MANAGEMENT

13 Service Providers

3 Target | 10 Bidder

14 Dealmakers

4 Target | 10 Bidder

£ 42 M

Value

08 Jul 2021|United States|Software

Target: HYPERFINE RESEARCH INC

Bidder: ELDRIDGE INDUSTRIES LLC

18 Service Providers

5 Target | 13 Bidder

39 Dealmakers

10 Target | 29 Bidder

£ 420 M

Value

26 Oct 2021|France|Biotechnology

Target: DNA SCRIPT

Bidder: CASDIN CAPITAL

19 Service Providers

3 Target | 16 Bidder

28 Dealmakers

3 Target | 25 Bidder

£ 119 M

Value

04 Jan 2022|France|Biotechnology

Target: DNA SCRIPT

Bidder: EUREKARE

13 Service Providers

3 Target | 10 Bidder

14 Dealmakers

4 Target | 10 Bidder

£ 148 M

Value

22 Mar 2022|United States|Biotechnology

Target: AFFINI-T THERAPEUTICS

Bidder: ERASCA VENTURES

7 Service Providers

2 Target | 5 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 132 M

Value

10 Mar 2022|United States|Health Care Services

Target: REFLEXION MEDICAL

Bidder: HILLENBRAND INC

4 Service Providers

2 Target | 2 Bidder

7 Dealmakers

4 Target | 3 Bidder

£ 60 M

Value

26 Apr 2022|United States|Biotechnology

Target: PHEAST

Bidder: CATALIO CAPITAL MANAGEMENT

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 59 M

Value

24 Mar 2022|United States|Biotechnology

Target: CELSIUS THERAPEUTICS

Bidder: THIRD ROCK VENTURES LLC

2 Service Providers

1 Target | 1 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 68 M

Value

13 Oct 2022|United States|Health Care Services

Target: ODYSSEY THERAPEUTICS

Bidder: SVB FINANCIAL GROUP

13 Service Providers

1 Target | 12 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 152 M

Value

05 Jan 2023|United States|Biotechnology

Target: METAGENOMI

Bidder: CATALIO CAPITAL MANAGEMENT

3 Service Providers

1 Target | 2 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 82 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy